Amazed,
I wonder if Kos has looked at selling the two products as a team?
I wonder if the idea that the two products have a strong industrial relationship, is playing on potential buyers minds...and them therefore wondering if having coldry without Matmor might cost them in the long run - competition via royalties to use Matmor in conjunction.
So maybe they should be sold together in a perfect world?
The recipient of BOTH products/patents would be a global monopoly. If they were split up between two competing companies, they might forever live out the RIO v's BHP war...not something to look forawrd to if you are a relatively small player.
For example, if Tincom bought one and Vale bought the other, who do you think might win a global tussle? The smaller would lose....so it might be best to own BOTH for this reason or be taken over.
Worth a thought...your posts are thought provoking and i only thought of this after reading your idea above.
L
- Forums
- ASX - By Stock
- ECT
- poll
poll, page-35
Featured News
Add ECT (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.343M |
Open | High | Low | Value | Volume |
0.2¢ | 0.2¢ | 0.2¢ | $78 | 38.82K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 5317530 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 15249389 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 5317530 | 0.002 |
28 | 36456532 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 15249389 | 23 |
0.004 | 7303519 | 10 |
0.005 | 3296859 | 21 |
0.006 | 3178567 | 7 |
0.007 | 918333 | 2 |
Last trade - 14.26pm 15/11/2024 (20 minute delay) ? |
Featured News
ECT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online